搜尋結果
Weight-Loss Upstart Viking Needs a Deal to Vie With Lilly and Novo
Bloomberg· 3 日前Hope for a weight-loss drug that’s better than Ozempic and Wegovy has sent Viking Therapeutics ...
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's ...
CNBC· 2 日前Big pharma is betting billions on an up-and-coming class of cancer treatments that some on Wall ...
Council Post: Go Forth, And Fight Aging
Forbes· 4 日前Steve is the Founder of GenAI Works and AI4Diversity. David Sinclair, Ph.D., a tenured ...
Will Destruction Of Smallpox Virus Get Postponed Again?
Forbes· 5 日前Is it finally time to eliminate the remaining stocks of variola (smallpox) virus for good? The ...
再鼎醫藥:國家藥監局批准鼎優樂新藥上市申請 - etnet Mobile|香港新聞財經資訊和生活平台
經濟通· 5 日前再鼎醫藥(09688)公布,中國國家藥品監督管理局已經批准了鼎優樂(舒巴坦鈉-度洛巴坦鈉)的新藥上市申請,用於治療18歲及以上患者由鮑曼-醋酸鈣不動桿菌複合 ...
財經智珠網 DB Power - 免費股票報價 HK Free Stock Quote
財經智珠網 DB Power· 5 日前news_finance_news_prnews - 財經智珠網為香港綜合財經新聞信息網站, 提供中英文在線財經新聞, 圖表, 圖表分析, 分析工具, 市場資訊, 上市公司概覽, 研究報 ...
therapeutics 相關
廣告